Psoriasis Treatment Market Share

  • Report ID: 4625
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Psoriasis Treatment Market Share

North American Market Forecast

The North American psoriasis treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. A strong presence of well- equipped infrastructure and rising long-term investment and advanced healthcare facilities is most likely to boost the market in the region. As per the data by the World Bank, 16.32% of the GDP was spent on healthcare services in the North America region in 2019. Further, the growing prevalence of skin disorders among people is also estimated to boost the growth of the market. In addition, people are increasing using topical pain relief ways in the form of creams and gels for the treatment of psoriasis, that is further expected to boost the market’s growth in the region. Additionally, rising initiatives in order to make people aware about the growing prevalence of psoriasis are also estimated to drive the market for psoriasis treatment. For instance, in the United States, August is recognized as "National Psoriasis Awareness Month" every year with the goal of raising awareness of the condition. The NPF-sponsored campaign presents a special chance to inform the public and dispel common misconceptions about the illness. It serves as a platform for patient education on a variety of subjects, including management of the inflammatory and frequently irritable condition, treatment, causes, and triggers.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4625
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of psoriasis treatment is evaluated at USD 32.76 million.

The psoriasis treatment market size was over USD 30.67 million in 2024 and is anticipated to exceed USD 88.31 million by the end of 2037, witnessing over 8.4% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of psoriasis and high demand for the treatment amid pandemic will boost the market growth.

North America industry is set to account for largest revenue share by 2037, impelled by strong presence of well- equipped infrastructure and rising long-term investment and advanced healthcare facilities in the region.

The major players in the market include LEO Pharma A/S, Amgen Inc., UCB S.A., Merck & co. Inc., Evelo Biosciences Inc., Sun Pharmaceutical Industries ltd., Johnson & Johnson Services Inc., Navartis AG, AbbVie Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample